![Kjell Rensfeldt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kjell Rensfeldt worked as a Principal at Biogen, Inc. and Q-Med AB. He also worked at Moberg Pharma AB from 2007 to 2018, where he held the position of Chief Medical Officer & VP-Clinical Development from 2012 to 2013.
Former positions of Kjell Rensfeldt
| Companies | Position | End |
|---|---|---|
| MOBERG PHARMA AB | Chief Tech/Sci/R&D Officer | 13/08/2018 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Health Technology |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
- Stock Market
- Insiders
- Kjell Rensfeldt
